检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]大连医科大学附属威海市立医院,山东威海264200 [2]威海市中心血站,山东威海264200
出 处:《医学检验与临床》2016年第9期9-11,共3页Medical Laboratory Science and Clinics
基 金:威海市科学技术发展计划项目(2015GNS049)
摘 要:目的:通过对红细胞血型免疫性抗体结果的分析,探讨其在临床输血中的意义。方法:应用微柱凝胶法对2014年5838例临床申请输血患者的标本进行不完全抗体筛查,对抗筛阳性及配血不合的供/受血者的标本进行抗体特异性鉴定。结果:5838人份患者血样中共检出免疫性抗体23例,阳性率0.39%;其中女14例,阳性率0.66%,男9例,阳性率0.24%,女性患者的阳性率明显高于男性(P〈0.05)。免疫性抗体特异性分布中以Rh系统血型抗体为主,其中抗-E(含复合抗体-Ec)抗体7例,占30.43%;交叉配血不合的供血者中有两例抗体筛查阳性,其中一例亦为抗-E阳性。结论:对供/受血者红细胞血型免疫性抗体和Rh系统抗原常规检测并同型输血,将有效降低溶血性输血反应的发生,保障临床输血安全、有效。Objective: To analyze the results of the RBC blood group immunity antibodies and explore its significance in the clinical blood transfusion. Methods: Microcolumn gel method was used for screening in 5838 cases of patients with transfusion during 2014, and identification of the antibody's specificity was conducted in positive screening samples with blood incompatibility. Results: There were 23 positive samples in 5838 cases of patients with immunity antibodies, and the positive rate was 0.39%. The positive rate in female was 0.66% (14/23) , and that in male was 0.24% (9/23) , with significantly higher ratios in female than men (P〈0.05) . Rh blood group system was dominant in the antibody' s specificity distribution, with 7 cases of anti-E (including composite anti- body-Ec) antibody, accounting for 30.43%. Two cases were positive for antibody screening in failed cross-matching blood donors, with one positive for anti-E. Conclusion: Detecting the R.BC blood group immunity antibodies and the antigens of Rh system for both blood donors and receptors, and keeping the same type of blood transfusion routine is necessary. It will not only effectively reduce the incidence of hemolytic transfusion reaction, but also helps to ensure blood transfusion safety and effective.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.15